SIGLEC10+ macrophages drive gastric cancer progression by suppressing CD8+ T cell function
Yixian Guo(Renji Hospital), Hong Lü(Chinese Academy of Sciences), Xu Liu(Peking University), Zeyu Wang(Anhui University), Wenyi Zhao(Shanghai Jiao Tong University), Gang Zhao(Shanghai University of Traditional Chinese Medicine), Yanying Shen(Shanghai Jiao Tong University), Jieqiong Chen(Shanghai Jiao Tong University), Shouyu Ke(Second Affiliated Hospital of Zhejiang University), Danhua Xu(Shanghai Jiao Tong University), Feng Xie(Shanghai Jiao Tong University)
Cited by 15
Related Papers
Glioma targeted therapy: insight into future of molecular approaches
|Molecular Cancer|2022|727
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
|Journal of Experimental & Clinical Cancer Research|2021|535
Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis
|The Lancet. Gastroenterology & hepatology|2017|317
Duodenal ulcer promoting gene of Helicobacter pylori
|Gastroenterology|2005|313
Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts
|Journal of Hematology & Oncology|2022|273